Low Evidence
Research Overview
MOTS-c Research for Metabolic Syndrome
An evidence-based overview of research examining MOTS-c in the context of metabolic syndrome. This page synthesizes findings from peer-reviewed literature.
Research Summary
Administered MOTS-c affected glucose-related measures in mice. Human diabetes comparisons measured endogenous peptide levels and cannot show that MOTS-c treatment improves metabolic disease. A trial in adults with prediabetes and overweight or obesity is registered without outcomes.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Always consult a healthcare provider before making health decisions.